Former UK pharma executive takes commission to court over Rhone-Poulenc, Hoechst merger
By Duncan Lumsden ( March 24, 2006, 16:00 GMT | Insight) -- A former chief executive of UK pharmaceuticals firm Albright and Wilson has taken the European Commission to court, over allegations the body was wrong to allow Rhone-Poulenc to merge with Hoechst because of a flawed earlier approval of a controversial parallel merger between the French firm's struggling subsidiary Rhodia and A&W.A former chief executive of UK pharmaceuticals firm Albright and Wilson has taken the European Commission to court, over allegations the body was wrong to allow Rhone-Poulenc to merge with Hoechst because of a flawed earlier approval of a controversial parallel merger between the French firm's struggling subsidiary Rhodia and A&W....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.